BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32334033)

  • 1. Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.
    Arsenault J; Parpia S; Goldberg M; Rakovitch E; Reiter H; Doherty M; Lukka H; Sussman J; Wright J; Julian J; Whelan T
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):943-948. PubMed ID: 32334033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
    Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
    Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
    Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
    Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
    Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
    Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
    Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
    Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiation treatment in the management of breast cancer.
    Gupta A; Ohri N; Haffty BG
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
    Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
    Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
    Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
    JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of clinical study on hypofractionated radiotherapy after breast-conserving surgery.
    Wei NN; Li F; Cai P; Yin HM; Zhu CM; Zhang Q; Li DJ
    Ann Palliat Med; 2020 Mar; 9(2):463-471. PubMed ID: 32233620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.
    Swanick CW; Lei X; Shaitelman SF; Schlembach PJ; Bloom ES; Fingeret MC; Strom EA; Tereffe W; Woodward WA; Stauder MC; Dvorak T; Thompson AM; Buchholz TA; Smith BD
    Cancer; 2016 Sep; 122(18):2886-94. PubMed ID: 27305037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
    Haussmann J; Budach W; Corradini S; Krug D; Jazmati D; Tamaskovics B; Bölke E; Pedotoa A; Kammers K; Matuschek C
    Radiat Oncol; 2023 Nov; 18(1):181. PubMed ID: 37919752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.